Save the Date:
Primary Mitochondrial Diseases
Hybrid Public Workshop: In-Person and Virtual
May 22, 2025
The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), will host a hybrid, public workshop exploring opportunities to optimize therapeutic development addressing primary mitochondrial diseases. The workshop will bring together patient advocates, academic researchers, regulated industry, and other key stakeholders to explore best practices in designing and interpreting clinical studies that can produce meaningful data to accelerate drug development for these rare diseases.
Watch for registration to open later this month.